Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melody Smith

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Open Forum Infectious Diseases|September 22, 2025
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Blood Cancer Journal|November 25, 2025
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohortShlomo Elias, Samantha Brown, Ogechukwu Egini, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Blood Advances|November 21, 2024
American Society of Hematology: building a comprehensive minority recruitment and retention professional programMargo R Rollins, Rahma M Warsame, Melody Smith, et al.
Blood Advances|May 12, 2025
Fatal Recurrence of IEC-HS Following Autologous Stem Cell Boost in Patients Receiving BCMA CAR-T Cell TherapySnegha Ananth, Nancy Eunice Torres, Bita Sahaf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2019
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34<sup>+</sup> Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Valkal Bhatt, Patrick Hilden, et al.
Blood Advances|April 27, 2022
Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider supportAlfred Ian Lee, Leah E Masselink, Laura M De Castro, et al.
Transplantation and Cellular Therapy|March 27, 2026
Superior Chronic GVHD-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell TransplantationAlfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, et al.
American Journal of Hematology|April 15, 2025
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage TreatmentsFateeha Furqan, Kwang W Ahn, Manmeet Kaur, et al.
Blood Advances|March 19, 2026
Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANSWilliam Lee Wang, Dasom Lee, Edna Cheung, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Open Forum Infectious Diseases|September 22, 2025
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Blood Cancer Journal|November 25, 2025
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohortShlomo Elias, Samantha Brown, Ogechukwu Egini, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Blood Advances|November 21, 2024
American Society of Hematology: building a comprehensive minority recruitment and retention professional programMargo R Rollins, Rahma M Warsame, Melody Smith, et al.
Blood Advances|May 12, 2025
Fatal Recurrence of IEC-HS Following Autologous Stem Cell Boost in Patients Receiving BCMA CAR-T Cell TherapySnegha Ananth, Nancy Eunice Torres, Bita Sahaf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2019
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34<sup>+</sup> Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Valkal Bhatt, Patrick Hilden, et al.
Blood Advances|April 27, 2022
Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider supportAlfred Ian Lee, Leah E Masselink, Laura M De Castro, et al.
Transplantation and Cellular Therapy|March 27, 2026
Superior Chronic GVHD-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell TransplantationAlfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, et al.
American Journal of Hematology|April 15, 2025
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage TreatmentsFateeha Furqan, Kwang W Ahn, Manmeet Kaur, et al.
Blood Advances|March 19, 2026
Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANSWilliam Lee Wang, Dasom Lee, Edna Cheung, et al.
Pageof 12